Form 4: Guardant Health's Co-CEO AmirAli Talasaz Reports Stock Transactions
SEC Form 4 Filing
Co-Chief Executive Officer of Guardant Health, AmirAli Talasaz, reports the vesting of restricted stock units and associated tax withholding.
Summary
- On March 31, 2024, AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., reported transactions involving common stock and restricted stock units.
- 11,461 shares of common stock were acquired through the vesting of restricted stock units.
- 4,509 shares were disposed of to cover tax withholding obligations related to the vesting of the restricted stock units at a price of $20.63 per share.
- Following these transactions, Talasaz directly owns 1,909,297 shares of Guardant Health common stock and 34,385 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of stock transactions (vesting of restricted stock units and tax withholding). |
| 03/31/2024 | First vesting date of restricted stock units. |
| 06/30/2024 | Second vesting date of restricted stock units. |
| 09/30/2024 | Third vesting date of restricted stock units. |
| 12/31/2024 | Fourth vesting date of restricted stock units. |
| 04/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.